GastroenterologyNews ECCO 2016 Oral Presentation 024. Mucosal healing and dysplasia surveillance in a large referral centre cohort of patients with Crohn’s Disease and Ulcerative Colitis treated with Vedolizumab M. Noman1, M. Ferrante1, R. Bisschops1, G. De Hertogh2, K. van den Broeck1, K. Rans1,…jwood@krftwrk.caApril 15, 2016
GastroenterologyNews ECCO 2016. Best Abstract 8. Predicting short and medium-term efficacy of the biosimilar infliximab: Trough levels/ADAs or clinical/biochemical markers play a more important role? P.A. Golovics1, Z. Vegh1, M. Rutka2, K. Gecse1, A. Balint2, K. Farkas2, J. Banai3, L.…jwood@krftwrk.caApril 15, 2016
